Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor (TCR) recognizing Amb a 1–derived peptide–MHC class II complexes is a pivotal molecular assembly in the development of ragweed pollen allergy. Amb a 1, a pectate lyase from Ambrosia artemisiifolia, is the immunodominant allergen responsible for most ragweed-induced Type I hypersensitivity reactions (Wopfner et al., 2005). When Amb a 1 peptides are presented by MHC class II molecules, specifically HLA-DR alleles, they are recognized by specific TCRs on CD4+ T cells, initiating a Th2-biased immune response (Jutel et al., 2016). This recognition leads to the secretion of pro-inflammatory cytokines like IL-4 and IL-13, which drive B-cell isotype switching to IgE. Therapeutic interventions, such as sublingual immunotherapy (e.g., Ragwitek), target this interaction by inducing peripheral T-cell tolerance or shifting the immune profile toward regulatory T-cells (Creticos et al., 2014). Monitoring the frequency and phenotype of T cells carrying these specific TCRs using pMHC tetramers serves as a valuable biomarker for assessing the efficacy of allergen-specific immunotherapy (FDA, 2014).
Induction of immunological tolerance through T-cell desensitization, anergy, or immune deviation from Th2 to Th1/Treg responses.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor recognizing Amb a 1–derived peptide–MHC class II complexes (TCR-Amb a 1-pMHCII).